| NCBVX | VMVAX | NCBVX / VMVAX | |
| Total Expense Ratio | 1.95 | 0.07 | 2,786% |
| Annual Report Gross Expense Ratio | 2.81 | 0.07 | 4,014% |
| Fund Existence | 27 years | 14 years | - |
| Gain YTD | 8.850 | 8.095 | 109% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 165M | 32.5B | 1% |
| Annual Yield % from dividends | 0.95 | 2.17 | 44% |
| Returns for 1 year | 7.04 | 4.27 | 165% |
| Returns for 3 years | 34.45 | 34.63 | 99% |
| Returns for 5 years | 84.80 | 63.75 | 133% |
| Returns for 10 years | 36.69 | 103.07 | 36% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ASGI | 20.80 | 0.11 | +0.53% |
| abrdn Global Infrastructure Income Fund | |||
| PPTY | 30.87 | 0.11 | +0.36% |
| Vident U.S. Diversified Real Estate ETF | |||
| UFEB | 36.07 | 0.12 | +0.33% |
| Innovator US Equity Ultra Bffr ETF™ Feb | |||
| SCHO | 24.45 | 0.02 | +0.08% |
| Schwab Short-Term US Treasury ETF™ | |||
| LFAX | 163.06 | N/A | N/A |
| LifeX 2061 Longevity Income ETF | |||